Related Experiment Video
Updated: Mar 20, 2026

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
IGF2BP3 Modulates the Interaction of Invasion-Associated Transcripts with RISC
Hanane Ennajdaoui1, Jonathan M Howard2, Timothy Sterne-Weiler1
1Department of Molecular, Cellular and Developmental Biology, University of California Santa Cruz, 1156 High Street, Santa Cruz, CA 95060, USA; The Donnelly Centre, University of Toronto, Toronto, ON M5S 1A1, Canada.
Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) influences pancreatic cancer progression by regulating gene expression. This study identifies IGF2BP3 targets and reveals its role in cell invasion and adhesion.
Area of Science:
- Molecular Biology
- Cancer Research
- RNA Biology
Background:
- Insulin-like growth factor 2 mRNA binding protein 3 (IGF2BP3) expression is linked to cancer malignancy.
- The specific functions of IGF2BP3 in pancreatic ductal adenocarcinoma (PDAC) pathogenesis are not fully understood.
Purpose of the Study:
- To investigate the IGF2BP3-RNA interaction network in PDAC cells.
- To elucidate the role of IGF2BP3 in PDAC cell behavior and RNA regulation.
Main Methods:
- Genome-wide approaches were used to identify direct mRNA targets of IGF2BP3.
- Individual nucleotide resolution crosslinking immunoprecipitation (iCLIP) was employed to map binding sites.
- Analysis of RNA-induced silencing complex (RISC) association with specific transcripts.
Main Results:
- 164 direct mRNA targets of IGF2BP3 were identified, involved in cell migration, proliferation, and adhesion.
- Loss of IGF2BP3 decreased PDAC cell invasiveness and altered focal adhesion junctions.
- IGF2BP3 binding sites significantly overlapped with microRNA (miRNA) binding sites, influencing miRNA-mRNA interactions.
Conclusions:
- IGF2BP3 modulates a malignancy-associated RNA regulon in PDAC.
- IGF2BP3 impacts PDAC progression by controlling miRNA-mediated gene regulation.
- Understanding IGF2BP3's role offers potential therapeutic insights for pancreatic cancer.
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Intracellular Signaling Affects Focal Adhesions
Some...
Leaky Scanning

